[Federal Register Volume 91, Number 38 (Thursday, February 26, 2026)]
[Notices]
[Pages 9600-9601]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2026-03900]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Patent and Trademark Office


Agency Information Collection Activities; Submission to the 
Office of Management and Budget for Review and Approval; Comment 
Request; Patent Term Extension and Adjustment

AGENCY: United States Patent and Trademark Office, Department of 
Commerce.

ACTION: Notice of information collection; request for comments.

-----------------------------------------------------------------------

SUMMARY: The United States Patent and Trademark Office (hereafter 
``USPTO'' or ``Agency'') will submit the following information 
collection request to the Office of Management and Budget (OMB) for 
review and clearance in accordance with the Paperwork Reduction Act of 
1995, on or after the date of publication of this notice. The USPTO 
invites comments on the information collection renewal of 0651-0020, 
which helps the USPTO assess the impact of its information collection 
requirements and minimize the reporting burden to the public. Public 
comments were previously requested via the Federal Register on November 
19, 2025, during a 60-day comment period (90 FR 52043). This notice 
allows for an additional 30 days for public comments.

DATES: To ensure consideration, you must submit comments regarding this 
information collection on or before March 30, 2026.

ADDRESSES: Written comments and recommendations for this information 
collection should be submitted within 30 days of the publication of 
this notice on the following website, http://www.reginfo.gov/public/do/PRAMain. Find this particular information collection by selecting 
``Currently under 30-day Review--Open for Public Comments'' or by using 
the search function and entering either the title of the information 
collection or the OMB Control Number, 0651-0020. Do not submit 
Confidential Business Information or otherwise sensitive or protected 
information.

FOR FURTHER INFORMATION CONTACT: 
     This information collection request may be viewed at 
http://www.reginfo.gov. Follow the instructions to view the Department 
of Commerce, USPTO information collections currently under review by 
OMB.
     Email: [email protected]. Include ``0651-
0020 information request'' in the subject line of the message.
     Mail: Justin Isaac, Office of the Chief Administrative 
Officer, United States Patent and Trademark Office, P.O. Box 1450, 
Alexandria, VA 22313-1450.
     Telephone: Jeffrey West, Senior Legal Advisor, 571-272-
2226.

SUPPLEMENTARY INFORMATION: 
    Title: Patent Term Extension and Adjustment.
    OMB Control Number: 0651-0020.
    Abstract: The patent term restoration portion of the Drug Price 
Competition and Patent Term Restoration Act of 1984 (Pub. L. 98-417), 
which is codified at 35 U.S.C. 156, permits the United States Patent 
and Trademark Office (USPTO) to extend the term of protection under a 
patent to compensate for delay during regulatory review and approval by 
the Food and Drug Administration (FDA) or

[[Page 9601]]

United States Department of Agriculture (USDA). Only patents for drug 
products, medical devices, food additives, or color additives are 
potentially eligible for extension. The maximum length that a patent 
may be extended under 35 U.S.C. 156 is five years. The USPTO 
administers 35 U.S.C. 156 through 37 CFR 1.710-1.791.
    This information collection covers information gathered in patent 
term extension applications submitted under 35 U.S.C. 156(d). Under 
this provision, an application for patent term extension must identify 
the approved product; the patent to be extended; and the claims 
included in the patent that cover the approved product, a method of 
using the approved product, or a method of manufacturing the approved 
product. 35 U.S.C. 156(d) also requires the submission of information 
that enables the USPTO to determine the eligibility of the patent for 
extension, and the rights that will be derived from the extension, and 
information to enable the USPTO and the Secretary of Health and Human 
Services or the Secretary of Agriculture to determine the period of the 
extension. Additionally, 35 U.S.C. 156(d) requires the applicant for 
patent term extension to provide a brief description of the activities 
undertaken by the applicant during the regulatory review period with 
respect to the approved product and the significant dates of these 
activities.
    This information collection also covers information gathered in 
requests for interim extensions pursuant to 35 U.S.C. 156(d)(5) and 
156(e)(2). Under 35 U.S.C. 156(d)(5), an interim extension may be 
granted if the applicable regulatory review period that began for a 
product is reasonably expected to extend beyond the expiration of the 
patent term in effect. Under 35 U.S.C. 156(e)(2), an interim extension 
may be granted if the term of an eligible patent for which an 
application for patent term extension has been submitted would expire 
before a certificate of extension is issued. In addition, this 
information collection covers requests for review of final eligibility 
decisions, and requests to withdraw an application requesting a patent 
term extension after it is submitted.
    Separate from the extension provisions of 35 U.S.C. 156, the USPTO 
may in some cases adjust the term of an original patent under the 
provisions of 35 U.S.C. 154 due to certain delays in the prosecution of 
the patent application, including delays caused by interference and 
derivation proceedings, secrecy orders, or appellate review by the 
Patent Trial and Appeal Board or a federal court in which the patent is 
issued pursuant to a decision reversing an adverse USPTO determination 
of patentability. The USPTO administers 35 U.S.C. 154 through 37 CFR 
1.701-1.705. The patent term provisions of 35 U.S.C. 154(b), as amended 
by Title IV, Subtitle D of the Intellectual Property and Communications 
Omnibus Reform Act of 1999, allow the applicant an opportunity to 
request reconsideration of the USPTO's patent term adjustment 
determination. This information collection covers information gathered 
in such a request.
    In addition, this information collection covers information 
collected when the USPTO reduces the amount of a granted patent term 
adjustment if delays were caused by an applicant's failure to make a 
reasonable effort to respond to a communication from the USPTO within 
three months of the communication's mailing date. Applicants may 
petition for reinstatement of a reduction in patent term adjustment 
with a showing that, in spite of all due care, the applicant was unable 
to respond to a communication from the USPTO within the three-month 
period.
    Forms: None.
    Type of Review: Extension and revision of a currently approved 
information collection.
    Affected Public: Private sector.
    Respondent's Obligation: Required to obtain or retain benefits.
    Frequency: On occasion.
    Estimated Number of Annual Respondents: 903 respondents.
    Estimated Number of Annual Responses: 903 responses.
    Estimated Time per Response: The USPTO estimates that the responses 
in this information collection will take the public approximately 1 
hour to 25 hours to complete. This includes the time to gather the 
necessary information, create the document, and submit the completed 
item to the USPTO.
    Estimated Total Annual Respondent Burden Hours: 6,807 hours.
    Estimated Total Annual Respondent Non-hourly Cost Burden: $489,440. 
The postage costs have increased since the publication of the 60-day 
Federal Register notice, from $11.20 to $12.25 for the Priority Mail 
legal flat rate envelope used for mailed submissions. As a result, the 
estimated postage costs have increased from $101 to $110. This accounts 
for the added $9 to the estimated total annual non-hourly cost burden.

Justin Isaac,
Information Collections Officer, Office of the Chief Administrative 
Officer, United States Patent and Trademark Office.
[FR Doc. 2026-03900 Filed 2-25-26; 8:45 am]
BILLING CODE 3510-16-P